Earnings Preview For Karyopharm Therapeutics
Portfolio Pulse from Benzinga Insights
Karyopharm Therapeutics (NASDAQ:KPTI) is set to release its latest quarterly earnings report on November 2, 2023. Analysts estimate an earnings per share (EPS) of $-0.28. The company's past performance shows a mixed impact on the share price post-earnings release. The stock is currently trading at $0.87, down 82.3% over the last 52-week period.
November 01, 2023 | 8:01 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Karyopharm Therapeutics is expected to report an EPS of $-0.28 in its upcoming earnings. The stock has seen a significant decline over the past year, which may influence investor sentiment.
The company's stock has been on a downward trend, losing over 82% of its value in the past year. This, coupled with the expected negative EPS, could potentially lead to further decline in the short term. However, any positive surprise in the earnings or future guidance could provide a boost to the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100